Home » Topics » Regulatory » Patents

Patents
RSS

New ERK2 inhibitors with oncolytic activity reported in recent Schering-Plough patent

Jan. 20, 2009

Novel Jak kinase inhibitors in early development at Novartis

Jan. 20, 2009

Boehringer Ingelheim divulges novel protein kinase inhibitors for use in treating cancer

Jan. 20, 2009

Novel protein kinase inhibitors with anticancer properties disclosed by Takeda

Jan. 19, 2009

Novel K(ATP) channel blockers claimed for cardiovascular disorders by sanofi-aventis

Jan. 19, 2009

Scientists at Janssen describe new analgesic FAAH inhibitors in recent patent

Jan. 19, 2009

Novel mgluR5 positive allosteric modulators developed at GSK for schizophrenia

Jan. 19, 2009

Analgesic calcium channel alpha2-delta subreceptor ligands claimed by Kyowa Hakko Kirin

Jan. 19, 2009

New non-nucleoside reverse transcriptase inhibitors prepared and tested at GSK

Jan. 16, 2009

Novel anticancer PI3Kalpha inhibitors developed at GSK

Jan. 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...